Filing Details
- Accession Number:
- 0001274737-23-000014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-03 16:38:11
- Reporting Period:
- 2023-03-02
- Accepted Time:
- 2023-03-03 16:38:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1274737 | Exagen Inc. | XGN | Services-Medical Laboratories (8071) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1788393 | Kamal Adawi | C/O Exagen Inc. 1261 Liberty Way Vista CA 92081 | Cfo And Corporate Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-03-02 | 3,667 | $2.30 | 188,271 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2021.
Billionaire Hedge Funds
